bioRxivBioinformaticsPreprint
Supervised non-negative matrix factorization on cell-free DNA fragmentomic features enhances early cancer detection
Trung Hieu TraniD, Ngoc Tan Pham, Van Thien Chi NguyeniD, Dac Ho Vo, Thị Huệ Hạnh NguyễniD, Thi Trang Tran, Tuan Trong TraniD, Truong Dang Huy Vo, Thi Huyen DaoiD, Huu Tam Phuc Nguyen, Thi Van Phan, Thị Minh Thi HàiD, Thị Thùy Dương NgôiD, Nhat Huy Tran, Nhat Thang TraniD, Thanh Quang Hoang, Viet Binh NguyeniD, Van Cuong Le, Xuan Chung Nguyen, Thi Minh Phuong Nguyen, Van Hung NguyeniD, Ngoc-Ha Tran, Thi Ngoc Dang, Trần Mạnh Hoàng, Phuc Nguyen Nguyen, , Trong Hieu NguyeniD
Abstract
BackgroundCell-free circulating DNA (cfDNA) fragments exhibit non-random patterns in their length (FLEN), end-motif (EM), and distance to nucleosome position (ND). While these cfDNA features have shown promise as inputs for machine learning and deep learning models in early cancer detection, most studies utilize them as raw inputs, overlooking the potential benefits of pre-processing to extract cancer-specific features. This study aims to enhance cancer detection accuracy by developing a novel approach to feature extraction from cfDNA fragmentomics. MethodsWe implemented a supervised non-negative matrix factorization (SNMF) algorithm to generate embedding vectors capturing cancer-specific signals within cfDNA fragmentomic features. These embeddings served as input for a machine learning model to classify cancer patients from healthy individuals. ResultsWe validated our framework using two datasets: an in-house cohort of 431 cancer patients and 442 healthy individuals (dataset 1), and a published cohort comprising 90 hepatocellular carcinoma (HCC) patients and 103 individuals with cirrhosis or hepatitis B (dataset 2). In dataset 1, we achieved an AUC of 94% in pan-cancer detection. In dataset 2, our framework achieved an AUC of 100% for HCC vs healthy classification, 99% for HCC vs non-HCC patients classification, and 96% for identifying HCC patients among a mixed group of non-HCC patients and healthy donors. ConclusionThis study demonstrates the efficiency of SNMF-transformed features in improving both pan-cancer detection and specific HCC detection. Our approach offers a significant advancement in leveraging cfDNA fragmentomics for early cancer detection, potentially enhancing diagnostic accuracy in clinical settings.
- organism: human
- assay: DNA methylation
- assay: whole-genome sequencing
- research focus: differential expression
- research focus: variant calling
- research focus: benchmarking
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Pan-cancer detection and typing by mining patterns in large genome-wide cell-free DNA sequencing datasets
Huiwen Che, Tatjana Jatsenko, … Joris Robert Vermeesch·Clinical ChemistryPeer-reviewed·Jun 29, 2022
- Cell-free DNA Fragmentation Profiling at Transcription Start Sites Improves upon Cancer-Type-Specific Region Selection for Cancer Detection
Bram Pronk, Stavros Makrodimitris, … Marcel J. T. Reinders·bioRxiv·Jun 26, 2026
- Integrated fragmentomic profile and 5-Hydroxymethylcytosine of capture-based low-pass sequencing data enables pan-cancer detection via cfDNA
Zhidong Zhang, Xuenan Pi, … Dan Xie·Translational OncologyPeer-reviewed·May 18, 2023
- cfMIND: A read-level methylation framework for accurate non- invasive disease detection using cell-free DNA
- Discovering fragment length signatures of circulating tumor DNA using Non-negative Matrix Factorization
Gabriel Renaud, Maibritt Nørgaard, … Søren Besenbacher·eLifePeer-reviewed·Jul 27, 2022
- Combining mutation detection with fragmentomics features leads to improved tumor-informed ctDNA detection
Yixin Lin, Carmen Oroperv, … Søren Besenbacher·bioRxiv·Apr 1, 2026